Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $8.28 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.16.
Market Cap
8.28T
Revenue
4.59T
Profits
201.12B
PE Ratio
41.16
Profit Margin
4.38%
Dividend Yield
0.43%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 908.57B | -0.25% | 2,998,810 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 552.02B | -0.30% | 7,353,782 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 375.09B | -0.68% | 5,128,999 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 348.09B | -1.53% | 7,783,866 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 290.91B | 1.53% | 1,803,544 | 60.44B |
| 6 | NVS | Novartis AG | 287.34B | 0.01% | 1,362,930 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 279.09B | -1.09% | 9,130,579 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 198.88B | 1.78% | 10,762,171 | 50.57B |
| 9 | AMGN | Amgen Inc. | 178.95B | 0.25% | 4,074,397 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 167.89B | 0.89% | 2,851,702 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 162.26B | 0.15% | 5,571,182 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 159.03B | 1.69% | 1,737,921 | 10.58B |
| 13 | ABT | Abbott Laboratories | 153.94B | -0.50% | 7,834,360 | 45.13B |
| 14 | PFE | Pfizer Inc. | 146.99B | 0.51% | 35,574,178 | 63.32B |
| 15 | SYK | Stryker Corporation | 123.25B | 1.18% | 3,020,449 | 25.27B |
| 16 | DHR | Danaher Corporation | 121.11B | 2.44% | 4,158,761 | 24.78B |
| 17 | BMY | Bristol-Myers Squibb Company | 119.54B | 0.39% | 8,547,167 | 48.48B |
| 18 | CVS | CVS Health Corporation | 119.02B | -0.96% | 7,886,210 | 405.62B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 109.25B | -0.89% | 1,784,848 | 12.22B |
| 20 | SNY | Sanofi | 107.01B | 2.57% | 2,736,872 | 54.60B |
| 21 | GSK | GSK plc | 101.90B | -0.53% | 2,898,791 | 43.29B |
| 22 | MDT | Medtronic plc | 100.34B | -0.55% | 9,665,665 | 35.48B |
| 23 | MCK | McKesson Corporation | 90.72B | -0.95% | 1,088,739 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 88.00B | -1.98% | 2,217,336 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 86.04B | -1.51% | 1,539,586 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 84.23B | -0.25% | 15,398,850 | 20.61B |
| 27 | CI | The Cigna Group | 74.89B | -2.81% | 1,291,840 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 66.11B | 3.09% | 1,165,759 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 51.53B | 0.60% | 1,866,681 | 28.34B |
| 30 | COR | Cencora, Inc. | 51.51B | -0.53% | 1,943,353 | 328.68B |
| 31 | ARGX | argenx SE | 49.93B | 0.81% | 401,098 | 4.74B |
| 32 | EW | Edwards Lifesciences Corporation | 47.77B | 0.99% | 4,029,516 | 6.30B |
| 33 | MDLN | Medline Inc. | 47.62B | -3.85% | 8,564,204 | 29.14B |
| 34 | CAH | Cardinal Health, Inc. | 46.66B | -0.57% | 1,756,927 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.67B | 1.30% | 619,025 | 4.45B |
| 36 | HLN | Haleon plc | 40.65B | 0.87% | 8,156,264 | 14.85B |
| 37 | BDX | Becton, Dickinson and Company | 40.49B | - | 2,479,098 | 22.23B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 39.96B | 0.73% | 6,312,446 | 17.35B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.85B | 1.42% | 799,241 | 4.29B |
| 40 | HUM | Humana Inc. | 36.51B | -2.08% | 1,593,978 | 137.20B |
| 41 | ONC | BeOne Medicines AG | 34.32B | 3.95% | 291,217 | 5.70B |
| 42 | WAT | Waters Corporation | 33.51B | 2.42% | 904,297 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 33.42B | 1.00% | 7,404,722 | 9.53B |
| 44 | ALC | Alcon Inc. | 32.82B | 1.51% | 3,014,666 | 10.63B |
| 45 | A | Agilent Technologies, Inc. | 32.15B | 2.90% | 3,018,294 | 7.07B |
| 46 | RVMD | Revolution Medicines, Inc. | 31.96B | 2.06% | 2,402,518 | - |
| 47 | RPRX | Royalty Pharma plc | 30.55B | 1.24% | 2,868,482 | 2.44B |
| 48 | RMD | ResMed Inc. | 30.44B | 1.00% | 1,787,316 | 5.54B |
| 49 | NTRA | Natera, Inc. | 29.35B | 4.53% | 1,513,928 | 2.50B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 29.23B | 4.35% | 8,740,653 | 20.98B |
| 51 | CNC | Centene Corporation | 28.78B | -1.47% | 3,111,678 | 178.33B |
| 52 | IQV | IQVIA Holdings Inc. | 28.62B | -0.97% | 2,160,359 | 16.63B |
| 53 | BIIB | Biogen Inc. | 27.73B | -1.45% | 919,894 | 9.94B |
| 54 | DXCM | DexCom, Inc. | 27.57B | 6.71% | 11,248,181 | 4.82B |
| 55 | VEEV | Veeva Systems Inc. | 26.92B | 1.01% | 1,815,065 | 3.20B |
| 56 | PHG | Koninklijke Philips N.V. | 25.38B | 2.65% | 1,502,591 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 23.94B | -0.51% | 485,814 | 3.17B |
| 58 | INSM | Insmed Incorporated | 23.39B | 0.47% | 2,989,433 | 819.56M |
| 59 | ROIV | Roivant Sciences Ltd. | 23.20B | 14.89% | 17,010,029 | 8.26M |
| 60 | BNTX | BioNTech SE | 22.85B | 2.93% | 848,371 | 3.23B |
| 61 | MTD | Mettler-Toledo International Inc. | 21.88B | 3.04% | 214,247 | 4.09B |
| 62 | WST | West Pharmaceutical Services, Inc. | 21.58B | 0.52% | 641,842 | 3.22B |
| 63 | ILMN | Illumina, Inc. | 21.47B | 0.17% | 1,455,926 | 4.39B |
| 64 | DGX | Quest Diagnostics Incorporated | 21.45B | 1.76% | 948,706 | 11.28B |
| 65 | STE | STERIS plc | 21.18B | 0.72% | 856,524 | 5.94B |
| 66 | LH | Labcorp Holdings Inc. | 21.11B | 1.47% | 400,192 | 14.14B |
| 67 | INCY | Incyte Corporation | 19.39B | 1.55% | 1,066,365 | 5.36B |
| 68 | VTRS | Viatris Inc. | 19.32B | 2.60% | 12,345,888 | 14.56B |
| 69 | MRNA | Moderna, Inc. | 19.09B | 5.25% | 4,777,769 | 2.23B |
| 70 | ZBH | Zimmer Biomet Holdings, Inc. | 16.52B | -0.81% | 2,569,077 | 8.41B |
| 71 | GMAB | Genmab A/S | 16.45B | 5.96% | 5,201,591 | 3.90B |
| 72 | THC | Tenet Healthcare Corporation | 16.14B | -2.08% | 1,800,257 | 21.46B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.55B | 0.20% | 1,168,560 | 3.10B |
| 74 | GH | Guardant Health, Inc. | 15.25B | 17.09% | 4,471,767 | 1.08B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 15.00B | 0.66% | 835,314 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 14.99B | 1.41% | 498,652 | 998.25M |
| 77 | SMMT | Summit Therapeutics Inc. | 13.89B | 12.87% | 4,630,131 | - |
| 78 | RGC | Regencell Bioscience Holdings Limited | 13.54B | 1.44% | 46,607 | - |
| 79 | BBIO | BridgeBio Pharma, Inc. | 13.36B | 3.36% | 2,609,039 | 579.96M |
| 80 | SOLV | Solventum Corporation | 13.18B | 1.87% | 1,347,978 | 8.26B |
| 81 | SNN | Smith & Nephew plc | 13.15B | 0.55% | 1,164,503 | 6.16B |
| 82 | PEN | Penumbra, Inc. | 12.88B | 0.25% | 449,750 | 1.45B |
| 83 | DVA | DaVita Inc. | 12.64B | 1.16% | 1,882,341 | 13.84B |
| 84 | EXEL | Exelixis, Inc. | 12.54B | 2.53% | 2,414,605 | 2.38B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.40B | 1.65% | 2,005,310 | 1.06B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.05B | 3.30% | 2,609,308 | 13.65B |
| 87 | MEDP | Medpace Holdings, Inc. | 12.05B | 0.47% | 376,204 | 2.68B |
| 88 | COO | The Cooper Companies, Inc. | 12.05B | 0.49% | 3,730,678 | 4.15B |
| 89 | FMS | Fresenius Medical Care AG | 12.03B | 0.45% | 710,476 | 22.32B |
| 90 | AXSM | Axsome Therapeutics, Inc. | 11.87B | 1.74% | 646,758 | 708.24M |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.84B | 0.32% | 361,114 | 1.13B |
| 92 | ALGN | Align Technology, Inc. | 11.70B | 5.30% | 1,518,298 | 4.10B |
| 93 | GMED | Globus Medical, Inc. | 11.41B | 5.13% | 2,403,403 | 3.10B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.40B | 1.34% | 1,805,857 | 3.58B |
| 95 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.87B | 5.41% | 1,582,583 | 622.01M |
| 96 | PODD | Insulet Corporation | 10.85B | 1.28% | 1,129,155 | 2.90B |
| 97 | CYTK | Cytokinetics, Incorporated | 10.69B | 3.03% | 2,379,527 | 105.82M |
| 98 | RVTY | Revvity, Inc. | 10.58B | -1.12% | 1,423,382 | 2.90B |
| 99 | EHC | Encompass Health Corporation | 10.51B | 1.17% | 641,831 | 6.07B |
| 100 | ELAN | Elanco Animal Health Incorporated | 10.41B | 5.30% | 8,000,785 | 4.89B |
| 101 | ENSG | The Ensign Group, Inc. | 10.33B | 1.35% | 377,081 | 5.27B |
| 102 | UHS | Universal Health Services, Inc. | 9.95B | -1.28% | 651,768 | 17.76B |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 9.70B | 0.78% | 2,189,666 | 3.24B |
| 104 | BAX | Baxter International Inc. | 9.69B | 2.40% | 6,801,150 | 11.32B |
| 105 | ABVX | ABIVAX Société Anonyme | 9.54B | 5.43% | 1,242,587 | 5.37M |
| 106 | MOH | Molina Healthcare, Inc. | 9.49B | -1.16% | 947,767 | 43.10B |
| 107 | MASI | Masimo Corporation | 9.36B | -0.01% | 750,334 | 1.56B |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 9.36B | 4.68% | 268,533 | 7.46M |
| 109 | KRYS | Krystal Biotech, Inc. | 8.90B | 2.98% | 197,427 | 417.30M |
| 110 | ICLR | ICON Public Limited Company | 8.79B | 1.36% | 859,077 | 8.10B |
| 111 | GKOS | Glaukos Corporation | 8.44B | 2.80% | 951,704 | 551.35M |
| 112 | IBRX | ImmunityBio, Inc. | 8.43B | 3.74% | 24,815,743 | 140.98M |
| 113 | HSIC | Henry Schein, Inc. | 8.34B | 0.43% | 1,358,991 | 13.38B |
| 114 | TEM | Tempus AI, Inc. | 8.24B | 0.77% | 4,379,431 | 1.36B |
| 115 | HALO | Halozyme Therapeutics, Inc. | 8.18B | 0.36% | 1,426,429 | 1.51B |
| 116 | NUVL | Nuvalent, Inc. | 8.08B | 1.31% | 403,377 | - |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 7.70B | 2.42% | 551,090 | 2.59B |
| 118 | CRL | Charles River Laboratories International, Inc. | 7.52B | 2.36% | 880,564 | 4.03B |
| 119 | HQY | HealthEquity, Inc. | 7.40B | 3.43% | 1,273,201 | 1.31B |
| 120 | ATR | AptarGroup, Inc. | 7.36B | 1.45% | 562,596 | 3.87B |
| 121 | TECH | Bio-Techne Corporation | 7.31B | 2.71% | 2,806,321 | 1.21B |
| 122 | QGEN | Qiagen N.V. | 7.26B | 2.48% | 1,647,636 | 2.10B |
| 123 | IMVT | Immunovant, Inc. | 7.25B | 35.26% | 19,566,590 | - |
| 124 | OSCR | Oscar Health, Inc. | 7.05B | -4.49% | 7,192,595 | 13.30B |
| 125 | CELC | Celcuity Inc. | 6.84B | 7.16% | 879,688 | - |
| 126 | GRFS | Grifols, S.A. | 6.82B | 4.46% | 1,090,467 | 8.58B |
| 127 | PCVX | Vaxcyte, Inc. | 6.81B | -3.30% | 4,138,797 | - |
| 128 | BRKR | Bruker Corporation | 6.74B | 3.92% | 1,865,801 | 3.46B |
| 129 | KYMR | Kymera Therapeutics, Inc. | 6.63B | 3.21% | 517,746 | 51.48M |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.49B | 2.55% | 371,678 | 74.06M |
| 131 | CORT | Corcept Therapeutics Incorporated | 6.34B | 1.44% | 1,115,257 | 769.10M |
| 132 | RGEN | Repligen Corporation | 6.30B | 2.97% | 1,182,471 | 763.34M |
| 133 | LNTH | Lantheus Holdings, Inc. | 6.26B | 3.44% | 809,370 | 1.55B |
| 134 | SYRE | Spyre Therapeutics, Inc. | 6.25B | 7.96% | 1,088,338 | - |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.21B | 3.93% | 496,738 | 217.17M |
| 136 | ALKS | Alkermes plc | 6.16B | -0.05% | 1,817,876 | 1.56B |
| 137 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.13% | 906,258 | 15.00M |
| 138 | APGE | Apogee Therapeutics, Inc. | 6.10B | 3.99% | 766,783 | - |
| 139 | TFX | Teleflex Incorporated | 5.98B | 1.84% | 641,701 | 2.13B |
| 140 | MIRM | Mirum Pharmaceuticals, Inc. | 5.91B | 1.36% | 553,909 | 569.61M |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.89B | 1.01% | 1,093,438 | 827.11M |
| 142 | PACS | PACS Group, Inc. | 5.86B | 0.76% | 752,142 | 5.43B |
| 143 | CHE | Chemed Corporation | 5.84B | 0.35% | 178,786 | 2.54B |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.80B | 1.72% | 915,240 | - |
| 145 | BLCO | Bausch + Lomb Corporation | 5.78B | - | 426,099 | 5.21B |
| 146 | CGON | CG Oncology, Inc. | 5.71B | 2.31% | 784,541 | 5.07M |
| 147 | BLTE | Belite Bio, Inc | 5.64B | 2.62% | 252,501 | - |
| 148 | TGTX | TG Therapeutics, Inc. | 5.63B | 0.84% | 1,413,940 | 700.35M |
| 149 | COGT | Cogent Biosciences, Inc. | 5.63B | 5.36% | 2,035,240 | - |
| 150 | LQDA | Liquidia Corporation | 5.49B | 2.98% | 1,754,960 | 288.07M |
| 151 | AVTR | Avantor, Inc. | 5.38B | 3.14% | 22,537,207 | 6.55B |
| 152 | HIMS | Hims & Hers Health, Inc. | 5.33B | 2.67% | 16,686,597 | 2.37B |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.29B | 1.17% | 1,045,349 | 7.50M |
| 154 | LEGN | Legend Biotech Corporation | 5.22B | 4.38% | 1,382,416 | 1.14B |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 4.85B | 3.56% | 676,999 | 1.34M |
| 156 | STVN | Stevanato Group S.p.A. | 4.85B | 2.42% | 379,076 | 1.39B |
| 157 | CRSP | CRISPR Therapeutics AG | 4.68B | 2.02% | 1,724,979 | 4.10M |
| 158 | CAI | Caris Life Sciences, Inc. | 4.44B | 4.95% | 2,715,785 | 907.29M |
| 159 | SHC | Sotera Health Company | 4.43B | 2.10% | 2,682,164 | 1.19B |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 4.36B | 4.80% | 260,297 | 274.48M |
| 161 | MANE | Veradermics, Incorporated | 4.34B | 5.25% | 371,878 | - |
| 162 | RDNT | RadNet, Inc. | 4.26B | 1.61% | 400,421 | 2.14B |
| 163 | HNGE | Hinge Health, Inc. | 4.24B | -0.40% | 1,252,653 | 646.34M |
| 164 | NAMS | NewAmsterdam Pharma Company N.V. | 4.18B | 6.02% | 1,271,750 | 22.57M |
| 165 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.18B | 1.76% | 447,303 | 754.05M |
| 166 | LIVN | LivaNova PLC | 4.05B | 1.08% | 712,020 | 1.43B |
| 167 | TVTX | Travere Therapeutics, Inc. | 4.04B | 2.91% | 1,596,100 | 536.20M |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 3.90B | 3.56% | 1,624,137 | 3.05B |
| 169 | NVST | Envista Holdings Corporation | 3.87B | 3.12% | 5,732,495 | 2.81B |
| 170 | MMSI | Merit Medical Systems, Inc. | 3.85B | 1.13% | 560,922 | 1.54B |
| 171 | IRTC | iRhythm Holdings, Inc. | 3.84B | 2.78% | 337,526 | 787.85M |
| 172 | BLLN | BillionToOne, Inc. | 3.84B | 1.32% | 676,380 | 354.54M |
| 173 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | 0.13% | 2,357,534 | 596.96M |
| 174 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.82B | 3.81% | 666,634 | 18.07M |
| 175 | WAY | Waystar Holding Corp. | 3.68B | -1.99% | 2,573,022 | 1.16B |
| 176 | ORKA | Oruka Therapeutics, Inc. | 3.66B | 5.51% | 1,428,224 | - |
| 177 | DOCS | Doximity, Inc. | 3.63B | 3.12% | 4,502,687 | 644.86M |
| 178 | VCYT | Veracyte, Inc. | 3.61B | 8.40% | 1,181,491 | 541.74M |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 3.59B | 2.29% | 1,704,816 | 1.10B |
| 180 | OGN | Organon & Co. | 3.53B | 0.30% | 2,471,305 | 6.16B |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.53B | 4.42% | 802,499 | - |
| 182 | OPCH | Option Care Health, Inc. | 3.49B | 6.57% | 5,233,178 | 5.67B |
| 183 | ERAS | Erasca, Inc. | 3.46B | 7.75% | 6,351,261 | - |
| 184 | ALHC | Alignment Healthcare, Inc. | 3.44B | 1.83% | 3,893,737 | 4.26B |
| 185 | VKTX | Viking Therapeutics, Inc. | 3.42B | 3.66% | 1,641,621 | - |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.41B | 1.08% | 96,957 | 803.79M |
| 187 | TWST | Twist Bioscience Corporation | 3.34B | 8.40% | 2,111,768 | 409.48M |
| 188 | MMED | MiniMed Group, Inc. | 3.27B | 6.80% | 811,153 | 2.99B |
| 189 | CON | Concentra Group Holdings Parent, Inc. | 3.25B | -0.43% | 783,836 | 2.23B |
| 190 | ICUI | ICU Medical, Inc. | 3.23B | 4.57% | 346,385 | 2.16B |
| 191 | BKD | Brookdale Senior Living Inc. | 3.19B | 0.68% | 3,308,550 | 3.00B |
| 192 | NHC | National HealthCare Corporation | 3.12B | 1.79% | 85,329 | 1.53B |
| 193 | ITGR | Integer Holdings Corporation | 3.11B | 1.16% | 441,907 | 1.86B |
| 194 | TNGX | Tango Therapeutics, Inc. | 3.05B | 3.84% | 3,446,778 | 56.99M |
| 195 | TXG | 10x Genomics, Inc. | 3.04B | 7.58% | 2,926,231 | 638.78M |
| 196 | WRBY | Warby Parker Inc. | 3.00B | -4.16% | 5,436,558 | 890.57M |
| 197 | DNLI | Denali Therapeutics Inc. | 2.99B | 3.98% | 1,379,713 | - |
| 198 | RCUS | Arcus Biosciences, Inc. | 2.99B | 4.35% | 797,494 | 236.00M |
| 199 | LFST | LifeStance Health Group, Inc. | 2.98B | -0.65% | 3,421,595 | 1.49B |
| 200 | PRVA | Privia Health Group, Inc. | 2.92B | -0.47% | 569,471 | 2.25B |
| 201 | DYN | Dyne Therapeutics, Inc. | 2.90B | 10.30% | 1,932,441 | - |
| 202 | GRAL | GRAIL, Inc. | 2.83B | 8.26% | 748,894 | 156.12M |
| 203 | SUPN | Supernus Pharmaceuticals, Inc. | 2.83B | 2.25% | 606,181 | 776.83M |
| 204 | ALMS | Alumis Inc. | 2.81B | 2.37% | 761,938 | 8.40M |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 2.79B | 5.71% | 1,229,164 | 535.08M |
| 206 | HAE | Haemonetics Corporation | 2.77B | 4.77% | 1,001,171 | 1.33B |
| 207 | BEAM | Beam Therapeutics Inc. | 2.70B | 2.96% | 2,137,154 | 164.01M |
| 208 | GPCR | Structure Therapeutics Inc. | 2.62B | 2.76% | 1,342,883 | - |
| 209 | GMRS | GMR Solutions Inc. | 2.61B | -3.23% | 3,095,139 | 5.74B |
| 210 | IDYA | IDEAYA Biosciences, Inc. | 2.61B | 4.70% | 739,104 | 225.27M |
| 211 | KLRA | Kailera Therapeutics, Inc. | 2.60B | 2.29% | 234,715 | - |
| 212 | IRON | Disc Medicine, Inc. | 2.56B | 4.62% | 453,958 | - |
| 213 | ARQT | Arcutis Biotherapeutics, Inc. | 2.56B | 4.97% | 2,325,926 | 415.62M |
| 214 | ELVN | Enliven Therapeutics, Inc. | 2.55B | 4.21% | 638,455 | - |
| 215 | RLAY | Relay Therapeutics, Inc. | 2.49B | 7.87% | 6,519,435 | 10.68M |
| 216 | VERA | Vera Therapeutics, Inc. | 2.49B | 4.12% | 870,612 | - |
| 217 | IMNM | Immunome, Inc. | 2.44B | 9.51% | 1,958,316 | 4.02M |
| 218 | CLDX | Celldex Therapeutics, Inc. | 2.43B | 2.49% | 738,857 | 865.00K |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.38B | 3.72% | 408,243 | 1.46B |
| 220 | HTFL | HeartFlow, Inc. | 2.36B | 2.93% | 1,091,812 | 191.42M |
| 221 | TMDX | TransMedics Group, Inc. | 2.35B | 2.83% | 1,313,272 | 635.89M |
| 222 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | 9.22% | 4,306,103 | - |
| 223 | NKTR | Nektar Therapeutics | 2.34B | 2.83% | 744,169 | 55.63M |
| 224 | LMAT | LeMaitre Vascular, Inc. | 2.32B | 0.10% | 251,829 | 256.28M |
| 225 | RARE | Ultragenyx Pharmaceutical Inc. | 2.29B | 4.10% | 1,547,855 | 670.00M |
| 226 | DFTX | Definium Therapeutics, Inc. | 2.28B | 4.25% | 1,492,734 | - |
| 227 | AXGN | Axogen, Inc. | 2.27B | - | 904,270 | 238.11M |
| 228 | KOD | Kodiak Sciences Inc. | 2.26B | 5.23% | 665,382 | - |
| 229 | PBH | Prestige Consumer Healthcare Inc. | 2.24B | 1.61% | 613,823 | 1.09B |
| 230 | ADPT | Adaptive Biotechnologies Corporation | 2.23B | 7.72% | 1,918,910 | 295.41M |
| 231 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.22B | -0.34% | 2,575,025 | 885.72M |
| 232 | ACHC | Acadia Healthcare Company, Inc. | 2.21B | -3.41% | 1,539,542 | 3.37B |
| 233 | ZLAB | Zai Lab Limited | 2.11B | 2.40% | 834,490 | 453.28M |
| 234 | NBTX | Nanobiotix S.A. | 2.08B | -6.58% | 96,370 | 38.27M |
| 235 | ESTA | Establishment Labs Holdings Inc. | 2.06B | 6.85% | 433,780 | 229.58M |
| 236 | NVCR | NovoCure Limited | 2.06B | 4.35% | 1,319,063 | 674.41M |
| 237 | BHC | Bausch Health Companies Inc. | 2.05B | 3.38% | 1,876,922 | 10.53B |
| 238 | SEM | Select Medical Holdings Corporation | 2.05B | 0.06% | 4,507,349 | 5.52B |
| 239 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | 2.25% | 1,347,951 | 298.30M |
| 240 | OMCL | Omnicell, Inc. | 2.03B | 2.05% | 373,580 | 1.23B |
| 241 | PGNY | Progyny, Inc. | 2.01B | 4.23% | 2,031,281 | 1.29B |
| 242 | HCM | HUTCHMED (China) Limited | 1.99B | -1.24% | 15,214 | 548.51M |
| 243 | TYRA | Tyra Biosciences, Inc. | 1.99B | -1.12% | 1,149,288 | - |
| 244 | ADMA | ADMA Biologics, Inc. | 1.98B | -0.81% | 4,541,972 | 509.86M |
| 245 | XRAY | DENTSPLY SIRONA Inc. | 1.97B | 1.03% | 6,400,273 | 3.68B |
| 246 | TRVI | Trevi Therapeutics, Inc. | 1.97B | 4.83% | 1,262,760 | - |
| 247 | VRDN | Viridian Therapeutics, Inc. | 1.95B | 10.39% | 3,535,881 | 70.92M |
| 248 | PHVS | Pharvaris N.V. | 1.93B | 1.73% | 209,588 | - |
| 249 | NEOG | Neogen Corporation | 1.92B | 5.75% | 3,325,719 | 870.56M |
| 250 | ASTH | Astrana Health, Inc. | 1.92B | -1.37% | 327,245 | 3.53B |
| 251 | CLOV | Clover Health Investments, Corp. | 1.89B | 2.57% | 6,096,292 | 2.21B |
| 252 | STOK | Stoke Therapeutics, Inc. | 1.89B | 1.12% | 950,654 | 32.08M |
| 253 | MESO | Mesoblast Limited | 1.85B | -0.21% | 207,818 | 65.38M |
| 254 | AAPG | Ascentage Pharma Group International | 1.82B | 4.16% | 11,435 | 82.08M |
| 255 | HRMY | Harmony Biosciences Holdings, Inc. | 1.82B | 3.09% | 669,436 | 899.11M |
| 256 | ZYME | Zymeworks Inc. | 1.81B | 1.80% | 542,864 | 81.26M |
| 257 | VCEL | Vericel Corporation | 1.81B | 2.64% | 634,039 | 292.09M |
| 258 | SRPT | Sarepta Therapeutics, Inc. | 1.81B | 2.88% | 2,296,615 | 2.18B |
| 259 | PLSE | Pulse Biosciences, Inc. | 1.81B | 4.57% | 256,778 | 751.00K |
| 260 | MD | Pediatrix Medical Group, Inc. | 1.80B | -2.35% | 751,681 | 1.93B |
| 261 | LKFT | Lakefront Biotherapeutics NV | 1.80B | 2.97% | 146,250 | 1.20B |
| 262 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 3.98% | 1,028,389 | 217.17M |
| 263 | SION | Sionna Therapeutics, Inc. | 1.78B | 4.83% | 392,330 | - |
| 264 | OCUL | Ocular Therapeutix, Inc. | 1.76B | 0.50% | 4,664,766 | 52.04M |
| 265 | ANAB | AnaptysBio, Inc. | 1.75B | 0.52% | 444,628 | 232.39M |
| 266 | SGRY | Surgery Partners, Inc. | 1.75B | -1.46% | 926,052 | 3.34B |
| 267 | ANIP | ANI Pharmaceuticals, Inc. | 1.74B | 2.09% | 345,618 | 923.71M |
| 268 | UFPT | UFP Technologies, Inc. | 1.74B | 3.46% | 178,833 | 608.85M |
| 269 | ADUS | Addus HomeCare Corporation | 1.71B | 1.26% | 196,944 | 1.45B |
| 270 | NTLA | Intellia Therapeutics, Inc. | 1.71B | 2.68% | 4,905,712 | 66.09M |
| 271 | SNDA | Sonida Senior Living, Inc. | 1.71B | 1.19% | 598,606 | 367.34M |
| 272 | RAPP | Rapport Therapeutics, Inc. | 1.71B | 3.93% | 260,069 | 20.00M |
| 273 | NRIX | Nurix Therapeutics, Inc. | 1.70B | 7.74% | 1,673,948 | 71.78M |
| 274 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 2.78% | 678,361 | 66.05M |
| 275 | CAPR | Capricor Therapeutics, Inc. | 1.68B | 7.76% | 1,123,726 | 11.13M |
| 276 | AVAH | Aveanna Healthcare Holdings Inc. | 1.67B | 0.66% | 1,542,142 | 2.52B |
| 277 | GENB | Generate Biomedicines, Inc. | 1.67B | 4.83% | 860,681 | 30.30M |
| 278 | SLS | SELLAS Life Sciences Group, Inc. | 1.67B | 18.18% | 18,441,717 | - |
| 279 | PVLA | Palvella Therapeutics, Inc. | 1.66B | 5.77% | 220,974 | - |
| 280 | OCS | Oculis Holding AG | 1.65B | -0.18% | 428,531 | 1.40M |
| 281 | STAA | STAAR Surgical Company | 1.65B | 1.38% | 652,000 | 290.38M |
| 282 | INVA | Innoviva, Inc. | 1.64B | 2.35% | 937,981 | 420.69M |
| 283 | INBX | Inhibrx Biosciences, Inc. | 1.61B | 0.46% | 428,247 | 1.30M |
| 284 | PRCT | PROCEPT BioRobotics Corporation | 1.60B | 8.49% | 1,459,146 | 322.02M |
| 285 | IOVA | Iovance Biotherapeutics, Inc. | 1.58B | 2.31% | 8,937,100 | 285.61M |
| 286 | TSHA | Taysha Gene Therapies, Inc. | 1.58B | 5.78% | 3,137,664 | 7.47M |
| 287 | GLUE | Monte Rosa Therapeutics, Inc. | 1.58B | 6.09% | 911,596 | 42.95M |
| 288 | RXRX | Recursion Pharmaceuticals, Inc. | 1.57B | 3.86% | 13,162,530 | 66.41M |
| 289 | NUVB | Nuvation Bio Inc. | 1.57B | 6.37% | 4,824,331 | 143.05M |
| 290 | QURE | uniQure N.V. | 1.55B | -0.36% | 984,678 | 18.09M |
| 291 | ARDX | Ardelyx, Inc. | 1.55B | 2.96% | 2,793,960 | 427.68M |
| 292 | GHRS | GH Research PLC | 1.55B | 2.73% | 268,179 | - |
| 293 | PRGO | Perrigo Company plc | 1.54B | 5.18% | 2,417,910 | 4.18B |
| 294 | NVAX | Novavax, Inc. | 1.52B | 4.16% | 4,949,590 | 596.34M |
| 295 | ENOV | Enovis Corporation | 1.52B | 2.72% | 596,658 | 2.28B |
| 296 | PGEN | Precigen, Inc. | 1.52B | 2.64% | 3,104,750 | 31.60M |
| 297 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.51B | 6.83% | 1,702,489 | -665.00K |
| 298 | IMTX | Immatics N.V. | 1.50B | 4.86% | 644,619 | 43.00M |
| 299 | IMCR | Immunocore Holdings plc | 1.50B | 2.11% | 535,995 | 412.81M |
| 300 | ATAI | AtaiBeckley Inc. | 1.50B | 3.28% | 3,458,863 | 3.49M |
| 301 | VIR | Vir Biotechnology, Inc. | 1.50B | 4.10% | 1,934,457 | 65.50M |
| 302 | MBX | MBX Biosciences, Inc. | 1.50B | 3.42% | 816,733 | - |
| 303 | URGN | UroGen Pharma Ltd. | 1.47B | 6.94% | 789,425 | 140.49M |
| 304 | ATRC | AtriCure, Inc. | 1.47B | 0.69% | 679,331 | 552.16M |
| 305 | CMPS | COMPASS Pathways plc | 1.47B | 7.94% | 3,927,739 | - |
| 306 | DMRA | Damora Therapeutics, Inc. | 1.46B | 0.46% | 180,035 | - |
| 307 | HCSG | Healthcare Services Group, Inc. | 1.43B | 0.14% | 587,394 | 1.85B |
| 308 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.15% | 5,543,683 | 114.48M |
| 309 | NNNN | Anbio Biotechnology | 1.40B | -1.55% | 24,302 | 8.65M |
| 310 | ALMR | Alamar Biosciences, Inc. | 1.40B | -1.71% | 196,961 | 87.16M |
| 311 | AHCO | AdaptHealth Corp. | 1.40B | 1.26% | 1,101,678 | 3.29B |
| 312 | ABCL | AbCellera Biologics Inc. | 1.40B | 12.84% | 8,513,066 | 79.21M |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.39B | 2.33% | 347,614 | 20.00M |
| 314 | PAHC | Phibro Animal Health Corporation | 1.37B | -0.27% | 485,019 | 1.50B |
| 315 | AHG | Akso Health Group | 1.37B | -1.84% | 3,347 | 14.84M |
| 316 | ARDT | Ardent Health, Inc. | 1.35B | -3.57% | 415,985 | 6.43B |
| 317 | AGL | agilon health, inc. | 1.35B | -8.23% | 444,263 | 5.82B |
| 318 | BCAX | Bicara Therapeutics Inc. | 1.34B | 2.00% | 375,528 | - |
| 319 | BHVN | Biohaven Ltd. | 1.33B | 5.48% | 2,904,049 | - |
| 320 | WGS | GeneDx Holdings Corp. | 1.33B | 6.17% | 1,143,982 | 442.68M |
| 321 | FTRE | Fortrea Holdings Inc. | 1.30B | -0.07% | 876,961 | 2.71B |
| 322 | SVRA | Savara Inc. | 1.29B | 7.63% | 1,157,723 | - |
| 323 | INSP | Inspire Medical Systems, Inc. | 1.27B | 3.79% | 957,503 | 915.25M |
| 324 | AVBP | ArriVent BioPharma, Inc. | 1.27B | 4.09% | 454,446 | - |
| 325 | ATEC | Alphatec Holdings, Inc. | 1.27B | 0.24% | 2,018,565 | 787.08M |
| 326 | SEPN | Septerna, Inc. | 1.26B | 5.66% | 226,724 | 72.26M |
| 327 | MPLT | MapLight Therapeutics, Inc. | 1.26B | 2.70% | 196,648 | - |
| 328 | MLTX | MoonLake Immunotherapeutics | 1.24B | 4.15% | 604,545 | - |
| 329 | ZBIO | Zenas BioPharma, Inc. | 1.23B | 9.64% | 569,125 | 10.00M |
| 330 | PNTG | The Pennant Group, Inc. | 1.23B | 0.97% | 230,552 | 1.02B |
| 331 | OLMA | Olema Pharmaceuticals, Inc. | 1.22B | 6.56% | 818,923 | - |
| 332 | KMTS | Kestra Medical Technologies, Ltd. | 1.21B | 4.85% | 309,958 | 83.72M |
| 333 | IART | Integra LifeSciences Holdings Corporation | 1.20B | 7.02% | 1,078,370 | 1.64B |
| 334 | WVE | Wave Life Sciences Ltd. | 1.19B | 0.81% | 4,643,961 | 71.80M |
| 335 | BLFS | BioLife Solutions, Inc. | 1.17B | 4.12% | 1,341,958 | 101.66M |
| 336 | AVLN | Avalyn Pharma Inc. | 1.17B | -0.28% | 181,017 | - |
| 337 | COAG | Hemab Therapeutics Holdings, Inc. | 1.17B | 4.05% | 161,849 | - |
| 338 | TDOC | Teladoc Health, Inc. | 1.17B | -1.97% | 2,730,146 | 2.51B |
| 339 | NEO | NeoGenomics, Inc. | 1.16B | 6.08% | 1,316,047 | 745.97M |
| 340 | AVNS | Avanos Medical, Inc. | 1.16B | -0.04% | 751,018 | 715.90M |
| 341 | IRMD | IRADIMED CORPORATION | 1.16B | 3.48% | 171,091 | 86.28M |
| 342 | JBIO | Jade Biosciences, Inc. | 1.15B | 6.67% | 595,978 | - |
| 343 | HROW | Harrow, Inc. | 1.15B | 0.59% | 508,909 | 268.68M |
| 344 | BFLY | Butterfly Network, Inc. | 1.15B | 7.07% | 4,852,367 | 102.92M |
| 345 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.14B | 4.98% | 3,443,847 | 204.73M |
| 346 | CNMD | CONMED Corporation | 1.11B | 2.29% | 322,431 | 1.37B |
| 347 | DBVT | DBV Technologies S.A. | 1.11B | 0.16% | 108,184 | 5.74M |
| 348 | COLL | Collegium Pharmaceutical, Inc. | 1.11B | 1.78% | 322,885 | 796.33M |
| 349 | AORT | Artivion, Inc. | 1.10B | -0.26% | 880,261 | 458.69M |
| 350 | CDNA | CareDx, Inc. | 1.09B | 3.02% | 1,320,583 | 412.82M |
| 351 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | 5.24% | 1,445,172 | 314.85M |
| 352 | IVA | Inventiva S.A. | 1.07B | 4.68% | 159,835 | 7.94M |
| 353 | AKTS | Aktis Oncology, Inc. | 1.05B | 2.86% | 124,229 | 8.28M |
| 354 | EYPT | EyePoint, Inc. | 1.05B | 5.75% | 1,082,275 | 7.61M |
| 355 | AMN | AMN Healthcare Services, Inc. | 1.04B | -0.22% | 1,387,324 | 3.42B |
| 356 | ALVO | Alvotech | 1.03B | 0.61% | 423,290 | 562.04M |
| 357 | TNDM | Tandem Diabetes Care, Inc. | 1.03B | 8.51% | 1,715,715 | 1.03B |
| 358 | CRVS | Corvus Pharmaceuticals, Inc. | 1.03B | 6.00% | 2,187,613 | - |
| 359 | INNV | InnovAge Holding Corp. | 1.02B | 4.16% | 304,782 | 949.17M |
| 360 | EVO | Evotec SE | 1.01B | 2.16% | 35,975 | 859.03M |
| 361 | CRON | Cronos Group Inc. | 1.01B | 2.30% | 2,369,577 | 159.54M |
| 362 | MNKD | MannKind Corporation | 1.00B | 9.80% | 5,175,749 | 360.78M |
| 363 | DRTS | Alpha Tau Medical Ltd. | 983.95M | 4.68% | 1,251,709 | - |
| 364 | OMDA | Omada Health, Inc. | 982.09M | -0.48% | 626,309 | 283.30M |
| 365 | LXRX | Lexicon Pharmaceuticals, Inc. | 981.47M | 3.76% | 1,700,074 | 69.64M |
| 366 | USPH | U.S. Physical Therapy, Inc. | 947.22M | 1.02% | 213,346 | 787.69M |
| 367 | ETON | Eton Pharmaceuticals, Inc. | 943.67M | 4.74% | 519,083 | 86.93M |
| 368 | PHAT | Phathom Pharmaceuticals, Inc. | 942.84M | 4.12% | 1,005,339 | 204.89M |
| 369 | OPK | OPKO Health, Inc. | 928.76M | 6.96% | 2,881,277 | 581.12M |
| 370 | SDGR | Schrödinger, Inc. | 920.56M | 2.75% | 1,321,198 | 254.91M |
| 371 | KURA | Kura Oncology, Inc. | 917.93M | 15.40% | 5,341,981 | 71.64M |
| 372 | BVS | Bioventus Inc. | 913.87M | 2.63% | 389,217 | 576.30M |
| 373 | PHAR | Pharming Group N.V. | 911.66M | 2.14% | 6,407 | 369.49M |
| 374 | PCRX | Pacira BioSciences, Inc. | 905.00M | 3.09% | 544,035 | 734.86M |
| 375 | OMER | Omeros Corporation | 896.01M | 3.43% | 1,052,838 | 9.89M |
| 376 | INMD | InMode Ltd. | 888.29M | 0.36% | 855,551 | 374.64M |
| 377 | MGTX | MeiraGTx Holdings plc | 887.20M | 4.93% | 792,981 | 79.76M |
| 378 | CGEM | Cullinan Therapeutics, Inc. | 880.69M | 1.06% | 988,509 | - |
| 379 | JANX | Janux Therapeutics, Inc. | 878.17M | 4.27% | 1,257,015 | 13.73M |
| 380 | AVR | Anteris Technologies Global Corp. | 874.16M | 11.95% | 1,682,598 | 1.85M |
| 381 | ORIC | ORIC Pharmaceuticals, Inc. | 870.58M | 5.52% | 980,278 | - |
| 382 | TALK | Talkspace, Inc. | 869.39M | -0.19% | 1,674,680 | 238.37M |
| 383 | SANA | Sana Biotechnology, Inc. | 865.49M | 1.63% | 2,944,183 | - |
| 384 | ABUS | Arbutus Biopharma Corporation | 863.24M | 4.05% | 2,400,620 | 191.45M |
| 385 | AZTA | Azenta, Inc. | 855.94M | 5.21% | 1,678,829 | 596.48M |
| 386 | GDRX | GoodRx Holdings, Inc. | 853.46M | - | 1,087,964 | 787.89M |
| 387 | TBPH | Theravance Biopharma, Inc. | 853.20M | 1.85% | 476,525 | 109.78M |
| 388 | VOR | Vor Biopharma Inc. | 842.59M | 10.05% | 1,427,269 | - |
| 389 | XNCR | Xencor, Inc. | 839.28M | 8.74% | 905,041 | 97.36M |
| 390 | SPTX | Seaport Therapeutics, Inc. | 836.78M | 0.77% | 266,061 | - |
| 391 | NUTX | Nutex Health Inc. | 836.36M | -3.84% | 151,248 | 879.95M |
| 392 | PSNL | Personalis, Inc. | 832.53M | 12.93% | 2,697,240 | 64.52M |
| 393 | ANNX | Annexon, Inc. | 825.77M | 2.65% | 1,808,614 | - |
| 394 | AURA | Aura Biosciences, Inc. | 823.94M | 1.08% | 486,317 | - |
| 395 | QDEL | QuidelOrtho Corporation | 812.15M | 4.66% | 1,978,851 | 2.66B |
| 396 | CTMX | CytomX Therapeutics, Inc. | 809.85M | 2.20% | 2,349,389 | 35.54M |
| 397 | GERN | Geron Corporation | 808.32M | 3.28% | 8,387,524 | 196.12M |
| 398 | ESPR | Esperion Therapeutics, Inc. | 805.76M | - | 7,812,572 | 418.24M |
| 399 | LBRX | LB Pharmaceuticals Inc | 803.81M | 2.79% | 177,257 | - |
| 400 | EVMN | Evommune, Inc. | 802.49M | 5.49% | 353,830 | 10.00M |
| 401 | ODTX | Odyssey Therapeutics, Inc. | 800.31M | 0.15% | 389,041 | 2.98M |
| 402 | AVTX | Avalo Therapeutics, Inc. | 799.13M | 0.12% | 1,316,567 | 59.00K |
| 403 | DRUG | Bright Minds Biosciences Inc. | 798.70M | 11.05% | 201,407 | - |
| 404 | AMPH | Amphastar Pharmaceuticals, Inc. | 797.20M | 1.46% | 868,757 | 720.53M |
| 405 | SSII | SS Innovations International, Inc. | 788.76M | -1.38% | 35,272 | 48.47M |
| 406 | SPRY | ARS Pharmaceuticals, Inc. | 774.57M | 8.79% | 1,625,614 | 98.99M |
| 407 | ABSI | Absci Corporation | 771.73M | 6.91% | 3,447,953 | 1.84M |
| 408 | RLMD | Relmada Therapeutics, Inc. | 752.05M | 1.99% | 763,927 | - |
| 409 | SGP | SpyGlass Pharma, Inc. | 731.71M | 3.25% | 37,948 | - |
| 410 | ANRO | Alto Neuroscience, Inc. | 728.40M | 1.61% | 211,729 | - |
| 411 | CERT | Certara, Inc. | 726.49M | 1.74% | 3,903,782 | 419.75M |
| 412 | BIOA | BioAge Labs, Inc. | 716.13M | -1.59% | 340,127 | 10.32M |
| 413 | LMRI | Lumexa Imaging Holdings, Inc. | 711.00M | 5.71% | 1,471,021 | 1.03B |
| 414 | TENX | Tenax Therapeutics, Inc. | 706.54M | 4.53% | 327,892 | - |
| 415 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 705.09M | 1.03% | 461,380 | - |
| 416 | HSTM | HealthStream, Inc. | 698.83M | -2.09% | 331,066 | 311.78M |
| 417 | DSGN | Design Therapeutics, Inc. | 693.27M | 5.82% | 2,502,233 | - |
| 418 | CBLL | CeriBell, Inc. | 686.76M | 6.72% | 350,921 | 95.07M |
| 419 | SIBN | SI-BONE, Inc. | 657.26M | -0.13% | 507,257 | 206.22M |
| 420 | ALLO | Allogene Therapeutics, Inc. | 655.79M | 0.53% | 5,201,371 | 22.00K |
| 421 | TLRY | Tilray Brands, Inc. | 645.32M | 3.84% | 3,426,693 | 858.28M |
| 422 | IRWD | Ironwood Pharmaceuticals, Inc. | 645.28M | 6.81% | 3,232,547 | 361.51M |
| 423 | SLDB | Solid Biosciences Inc. | 636.97M | 6.41% | 1,059,431 | - |
| 424 | ACRS | Aclaris Therapeutics, Inc. | 632.68M | 1.80% | 993,108 | 8.37M |
| 425 | CBIO | Crescent Biopharma, Inc. | 628.36M | 2.33% | 107,803 | 11.88M |
| 426 | CRMD | CorMedix Inc. | 622.12M | 1.41% | 1,418,725 | 400.05M |
| 427 | BWAY | BrainsWay Ltd. | 608.13M | 2.62% | 118,438 | 56.22M |
| 428 | CSTL | Castle Biosciences, Inc. | 607.51M | 4.32% | 425,112 | 339.92M |
| 429 | ZVRA | Zevra Therapeutics, Inc. | 605.34M | 0.39% | 1,028,772 | 122.29M |
| 430 | ARVN | Arvinas, Inc. | 587.14M | 6.43% | 839,850 | 89.40M |
| 431 | EIKN | Eikon Therapeutics, Inc. | 577.12M | 0.19% | 236,602 | - |
| 432 | CADL | Candel Therapeutics, Inc. | 564.91M | 0.65% | 1,434,891 | - |
| 433 | MDXG | MiMedx Group, Inc. | 564.50M | 4.12% | 1,195,649 | 389.42M |
| 434 | TRAX | First Tracks Biotherapeutics, Inc. | 564.04M | -2.97% | 491,175 | - |
| 435 | CABA | Cabaletta Bio, Inc. | 560.89M | 5.20% | 3,290,919 | - |
| 436 | TCMD | Tactile Systems Technology, Inc. | 560.30M | 2.39% | 196,143 | 343.52M |
| 437 | NPCE | NeuroPace, Inc. | 554.71M | 2.65% | 181,963 | 99.53M |
| 438 | GYRE | Gyre Therapeutics, Inc. | 551.89M | -3.51% | 95,332 | 117.05M |
| 439 | VALN | Valneva SE | 549.16M | 2.78% | 62,459 | 180.25M |
| 440 | ALT | Altimmune, Inc. | 548.42M | 2.92% | 2,229,241 | 36.00K |
| 441 | TECX | Tectonic Therapeutic, Inc. | 544.19M | 5.68% | 180,790 | - |
| 442 | CERS | Cerus Corporation | 538.99M | -0.37% | 3,093,379 | 216.56M |
| 443 | PHR | Phreesia, Inc. | 537.75M | -3.49% | 1,869,308 | 480.59M |
| 444 | RIGL | Rigel Pharmaceuticals, Inc. | 533.23M | 1.84% | 308,820 | 299.77M |
| 445 | AGMB | AgomAb Therapeutics NV | 526.95M | 1.81% | 38,019 | - |
| 446 | XOMA | XOMA Royalty Corporation | 526.47M | 1.06% | 111,378 | 48.56M |
| 447 | AQST | Aquestive Therapeutics, Inc. | 523.13M | 1.96% | 1,204,145 | 50.27M |
| 448 | KYTX | Kyverna Therapeutics, Inc. | 518.74M | -1.49% | 849,359 | - |
| 449 | STRO | Sutro Biopharma, Inc. | 515.76M | -1.71% | 374,099 | 99.61M |
| 450 | PRME | Prime Medicine, Inc. | 511.15M | 4.81% | 2,164,773 | 4.03M |
| 451 | PROK | ProKidney Corp. | 510.31M | 9.03% | 1,278,822 | 889.00K |
| 452 | DNA | Ginkgo Bioworks Holdings, Inc. | 504.31M | 4.89% | 691,919 | 151.40M |
| 453 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 454 | CLYM | Climb Bio, Inc. | 502.53M | 9.02% | 697,415 | - |
| 455 | CTNM | Contineum Therapeutics, Inc. | 500.60M | 4.94% | 202,419 | - |
| 456 | FBRX | Forte Biosciences, Inc. | 496.29M | 1.20% | 133,696 | - |
| 457 | ANGO | AngioDynamics, Inc. | 492.27M | 3.23% | 368,993 | 313.73M |
| 458 | OFIX | Orthofix Medical Inc. | 491.12M | 0.50% | 298,314 | 825.37M |
| 459 | PRTA | Prothena Corporation plc | 489.50M | 3.09% | 624,876 | 57.94M |
| 460 | CTKB | Cytek Biosciences, Inc. | 486.87M | 5.60% | 860,978 | 204.17M |
| 461 | SRTA | Strata Critical Medical, Inc. | 479.36M | 6.13% | 889,150 | 228.58M |
| 462 | KIDS | OrthoPediatrics Corp. | 475.17M | 1.48% | 133,359 | 243.30M |
| 463 | IMMX | Immix Biopharma, Inc. | 473.93M | 0.90% | 644,146 | - |
| 464 | ACHV | Achieve Life Sciences, Inc. | 469.15M | 2.70% | 1,139,708 | - |
| 465 | WEAV | Weave Communications, Inc. | 468.64M | 1.55% | 1,111,008 | 248.72M |
| 466 | STTK | Shattuck Labs, Inc. | 466.34M | 6.56% | 307,566 | 1.00M |
| 467 | FLGT | Fulgent Genetics, Inc. | 466.05M | 2.88% | 609,920 | 320.35M |
| 468 | OCGN | Ocugen, Inc. | 460.39M | 4.62% | 4,044,111 | 4.47M |
| 469 | UPB | Upstream Bio, Inc. | 457.67M | 4.73% | 593,026 | 3.32M |
| 470 | KMDA | Kamada Ltd. | 455.37M | 3.55% | 70,924 | 181.68M |
| 471 | ANL | Adlai Nortye Ltd. | 454.40M | 6.17% | 262,727 | 5.00M |
| 472 | VTVT | vTv Therapeutics Inc. | 454.19M | 0.30% | 54,711 | 36.84M |
| 473 | PRLD | Prelude Therapeutics Incorporated | 452.60M | 5.39% | 386,110 | 16.72M |
| 474 | BBNX | Beta Bionics, Inc. | 450.52M | 7.32% | 660,109 | 110.24M |
| 475 | FDMT | 4D Molecular Therapeutics, Inc. | 442.78M | 0.71% | 523,457 | 88.24M |
| 476 | MNPR | Monopar Therapeutics Inc. | 435.09M | 17.66% | 337,811 | - |
| 477 | EVH | Evolent Health, Inc. | 434.18M | -0.77% | 2,590,221 | 1.89B |
| 478 | NRC | NRC Health | 434.06M | 2.72% | 135,756 | 138.64M |
| 479 | EOLS | Evolus, Inc. | 433.98M | 2.49% | 777,575 | 301.79M |
| 480 | AUTL | Autolus Therapeutics plc | 431.15M | -0.61% | 924,917 | 92.62M |
| 481 | CATX | Perspective Therapeutics, Inc. | 429.95M | 3.86% | 825,762 | 618.00K |
| 482 | VREX | Varex Imaging Corporation | 426.94M | 8.69% | 485,481 | 857.50M |
| 483 | PRTC | PureTech Health plc | 426.13M | 1.99% | 7,177 | 4.66M |
| 484 | REPL | Replimune Group, Inc. | 426.07M | 9.79% | 6,041,664 | - |
| 485 | NGNE | Neurogene Inc. | 425.86M | 0.26% | 186,366 | 925.00K |
| 486 | FULC | Fulcrum Therapeutics, Inc. | 423.12M | 7.45% | 518,173 | 80.00M |
| 487 | MOBI | Mobia Medical, Inc. | 421.84M | 2.33% | 71,246 | 32.04M |
| 488 | EBS | Emergent BioSolutions Inc. | 420.51M | 1.12% | 614,630 | 676.80M |
| 489 | TOI | The Oncology Institute, Inc. | 419.93M | 2.44% | 2,799,316 | 545.76M |
| 490 | ASMB | Assembly Biosciences, Inc. | 417.34M | -0.98% | 121,787 | 71.10M |
| 491 | LAB | Standard BioTools Inc. | 413.79M | 6.00% | 1,451,960 | 86.26M |
| 492 | OVID | Ovid Therapeutics Inc. | 413.56M | -0.42% | 915,780 | 7.12M |
| 493 | ADCT | ADC Therapeutics SA | 412.10M | 3.18% | 664,923 | 79.18M |
| 494 | SGMT | Sagimet Biosciences Inc. | 410.65M | 1.68% | 732,036 | - |
| 495 | CCRN | Cross Country Healthcare, Inc. | 406.52M | 0.08% | 628,429 | 1.00B |
| 496 | IPSC | Century Therapeutics, Inc. | 405.80M | 6.13% | 496,324 | 109.16M |
| 497 | LXEO | Lexeo Therapeutics, Inc. | 402.03M | 14.29% | 1,834,966 | - |
| 498 | LYEL | Lyell Immunopharma, Inc. | 401.79M | 6.76% | 82,095 | 31.00K |
| 499 | CGC | Canopy Growth Corporation | 396.24M | 4.06% | 8,991,424 | 203.04M |
| 500 | ENTA | Enanta Pharmaceuticals, Inc. | 395.76M | -1.09% | 161,204 | 69.21M |